circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
Am J Respir Crit Care Med
.
2022 Jan 15;205(2):252-253.
doi: 10.1164/rccm.202108-1868LE.
Authors
Xishi Sun
1
2
,
Riken Chen
3
,
Xiaoyun Yao
4
,
Zhenzhen Zheng
2
,
Chaoyu Wang
5
,
Jiahui Chen
4
,
Junfen Cheng
2
Affiliations
1
Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China.
2
The Second Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China.
3
The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China.
4
Guangdong Provincial Agricultural Reclamation Central Hospital Zhanjiang, Guangdong, China.
5
Taishan Hospital of Traditional Chinese Medicine Jiangmen, Guangdong, China.
PMID:
34739355
PMCID:
PMC8787255
DOI:
10.1164/rccm.202108-1868LE
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biomarkers
Familial Primary Pulmonary Hypertension
Humans
Hypertension, Pulmonary* / diagnosis
Pulmonary Arterial Hypertension*
Substances
Biomarkers